Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.
暂无分享,去创建一个
[1] K. Lim,et al. Eteplirsen in the treatment of Duchenne muscular dystrophy , 2017, Drug design, development and therapy.
[2] E. Füchtbauer,et al. Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle , 2015, Pflügers Archiv - European Journal of Physiology.
[3] D. Swandulla,et al. Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy , 2015, Biology.
[4] Paul L Huang,et al. Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. , 2015, Human molecular genetics.
[5] B. Loos,et al. AHNAK: the giant jack of all trades. , 2014, Cellular Signalling.
[6] H. Brinkmeier,et al. Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin‐deficient muscle , 2014, Proteomics. Clinical applications.
[7] A. López de Munain,et al. Dysregulation of calcium homeostasis in muscular dystrophies , 2014, Expert Reviews in Molecular Medicine.
[8] G. Reiser,et al. Putative roles of Ca2+‐independent phospholipase A2 in respiratory chain‐associated ROS production in brain mitochondria: influence of docosahexaenoic acid and bromoenol lactone , 2014, Journal of neurochemistry.
[9] P. Muñoz-Cánoves,et al. Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne Muscular Dystrophy , 2014, Skeletal Muscle.
[10] C. Spurney,et al. Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy , 2014, Muscle & nerve.
[11] D. Goodlett,et al. Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting. , 2014, Human molecular genetics.
[12] H. Sweeney,et al. Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function , 2014, Neuromuscular Disorders.
[13] M. Sardiello,et al. Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy , 2014, Nature Communications.
[14] E. Barton,et al. Caspase-12 ablation preserves muscle function in the mdx mouse. , 2014, Human molecular genetics.
[15] H. Westerblad,et al. Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness , 2014, Annals of the rheumatic diseases.
[16] E. Hoffman,et al. Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road? , 2014, Science Translational Medicine.
[17] M. Gasperini,et al. Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. , 2014, Human molecular genetics.
[18] T. Palmer,et al. Cavin-1: caveolae-dependent signalling and cardiovascular disease. , 2014, Biochemical Society transactions.
[19] M. Adams,et al. Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells , 2014, British Journal of Cancer.
[20] R. Goldschmeding,et al. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. , 2013, Human molecular genetics.
[21] R. Finkel,et al. Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy , 2013, PloS one.
[22] L. Ségalat,et al. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy. , 2013, Human molecular genetics.
[23] T. Yoshimori,et al. The autophagosome: origins unknown, biogenesis complex , 2013, Nature Reviews Molecular Cell Biology.
[24] F. Muntoni,et al. 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8–10 December 2012, Naarden, The Netherlands , 2013, Neuromuscular Disorders.
[25] Eric P Hoffman,et al. Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. , 2013, Discovery medicine.
[26] E. Ralston,et al. Microtubules that form the stationary lattice of muscle fibers are dynamic and nucleated at Golgi elements , 2013, The Journal of cell biology.
[27] C. Buechler,et al. Adiponectin receptor 1 C-terminus interacts with PDZ-domain proteins such as syntrophins. , 2013, Experimental and molecular pathology.
[28] U. Ruegg. Pharmacological prospects in the treatment of Duchenne muscular dystrophy , 2013, Current opinion in neurology.
[29] T. Partridge. The mdx mouse model as a surrogate for Duchenne muscular dystrophy , 2013, The FEBS journal.
[30] C. McDonald,et al. Why short stature is beneficial in duchenne muscular dystrophy , 2013, Muscle & nerve.
[31] E. McNally,et al. Modifying muscular dystrophy through transforming growth factor‐β , 2013, The FEBS journal.
[32] Stephan Lange,et al. Cypher/ZASP Is a Novel A-kinase Anchoring Protein* , 2013, The Journal of Biological Chemistry.
[33] Haixia Huang,et al. Caveolae Regulation of Mechanosensitive Channel Function in Myotubes , 2013, PloS one.
[34] K. Flanigan,et al. Identification of New Dystroglycan Complexes in Skeletal Muscle , 2013, PloS one.
[35] Michael Berk,et al. The chemistry and biological activities of N-acetylcysteine. , 2013, Biochimica et biophysica acta.
[36] Jay J. Han,et al. The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measur , 2013, Muscle & nerve.
[37] Jian Yang,et al. Structure and function of the β subunit of voltage-gated Ca²⁺ channels. , 2013, Biochimica et biophysica acta.
[38] J. Penninger,et al. Linking cytoarchitecture to metabolism: sarcolemma-associated plectin affects glucose uptake by destabilizing microtubule networks in mdx myofibers , 2013, Skeletal Muscle.
[39] Elaine Minatel,et al. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice. , 2013, Clinical nutrition.
[40] K. Davies,et al. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches , 2013, Nature Reviews Genetics.
[41] M. Hammadi,et al. Modulation of ER stress and apoptosis by endoplasmic reticulum calcium leak via translocon during unfolded protein response: involvement of GRP78 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] W. Bloch,et al. Skeletal Muscle Function during Exercise—Fine-Tuning of Diverse Subsystems by Nitric Oxide , 2013, International journal of molecular sciences.
[43] E. Clementi,et al. Autophagy as a new therapeutic target in Duchenne muscular dystrophy , 2013, Cell Death and Disease.
[44] L. Kunkel,et al. Zebrafish based small molecule screens for novel DMD drugs. , 2013, Drug discovery today. Technologies.
[45] J. Mendell,et al. AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[46] M. Jackson,et al. Studies of mitochondrial and nonmitochondrial sources implicate nicotinamide adenine dinucleotide phosphate oxidase(s) in the increased skeletal muscle superoxide generation that occurs during contractile activity. , 2013, Antioxidants & redox signaling.
[47] Jimmy D Bell,et al. Ca2+‐dependent proteolysis of junctophilin‐1 and junctophilin‐2 in skeletal and cardiac muscle , 2013, The Journal of physiology.
[48] J. Lawler,et al. Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy , 2013, Journal of Muscle Research and Cell Motility.
[49] Y. Hathout,et al. Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion , 2013, Cellular and Molecular Life Sciences.
[50] Robert G. Parton,et al. Caveolae as plasma membrane sensors, protectors and organizers , 2013, Nature Reviews Molecular Cell Biology.
[51] Louise R. Rodino-Klapac,et al. Update on the Treatment of Duchenne Muscular Dystrophy , 2013, Current Neurology and Neuroscience Reports.
[52] L. Wells. The O-Mannosylation Pathway: Glycosyltransferases and Proteins Implicated in Congenital Muscular Dystrophy* , 2013, The Journal of Biological Chemistry.
[53] E. Hoffman,et al. Identification of Disease Specific Pathways Using in Vivo SILAC Proteomics in Dystrophin Deficient mdx Mouse* , 2013, Molecular & Cellular Proteomics.
[54] Jamie L. Marshall,et al. Sarcospan: a small protein with large potential for Duchenne muscular dystrophy , 2013, Skeletal Muscle.
[55] R. Elashoff,et al. Tadalafil Alleviates Muscle Ischemia in Patients with Becker Muscular Dystrophy , 2012, Science Translational Medicine.
[56] P. Gervais,et al. Exploration of Lipid Metabolism in Relation with Plasma Membrane Properties of Duchenne Muscular Dystrophy Cells: Influence of L-Carnitine , 2012, PloS one.
[57] D. Duan,et al. α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding , 2012, Proceedings of the National Academy of Sciences.
[58] Xiaoli Zhao,et al. Orai1 Mediates Exacerbated Ca2+ Entry in Dystrophic Skeletal Muscle , 2012, PloS one.
[59] S. Froehner,et al. The Light Chains of Microtubule-Associated Proteins MAP1A and MAP1B Interact with α1-Syntrophin in the Central and Peripheral Nervous System , 2012, PloS one.
[60] S. Winder,et al. The inside and out of dystroglycan post-translational modification , 2012, Neuromuscular Disorders.
[61] S. Winder,et al. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. , 2012, Human molecular genetics.
[62] K. Anderson,et al. β2-syntrophin and Par-3 promote an apicobasal Rac activity gradient at cell-cell junctions by differentially regulating Tiam1 activity , 2012, Nature Cell Biology.
[63] J. Mendell,et al. Gene therapy for muscular dystrophy: Lessons learned and path forward , 2012, Neuroscience Letters.
[64] P. Lesault,et al. Macrophages Improve Survival, Proliferation and Migration of Engrafted Myogenic Precursor Cells into MDX Skeletal Muscle , 2012, PloS one.
[65] T. Grimm,et al. Survival in Duchenne muscular dystrophy , 2012, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[66] F. Leturcq,et al. G.P.75 Variable phenotype of del45–55 Becker patients correlated to nNOSμ mislocalization and RYR1 hypernitrosylation , 2012, Neuromuscular Disorders.
[67] M. Welte,et al. Organelle positioning in muscles requires cooperation between two KASH proteins and microtubules , 2012, The Journal of cell biology.
[68] J. Beavo,et al. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy , 2012, The Journal of pathology.
[69] Shuo Lin,et al. Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS , 2012, PloS one.
[70] Michael A. Freitas,et al. Proteomic Analysis Reveals New Cardiac-Specific Dystrophin-Associated Proteins , 2012, PloS one.
[71] S. Winder,et al. A new twist to coiled coil , 2012, FEBS letters.
[72] F. Sbrana,et al. Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy , 2012, Science Signaling.
[73] S. Schenk,et al. NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise. , 2012, American journal of physiology. Endocrinology and metabolism.
[74] M. Young,et al. Biglycan: a promising new therapeutic for neuromuscular and musculoskeletal diseases. , 2012, Current opinion in genetics & development.
[75] G. McConell,et al. Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. , 2012, American journal of physiology. Endocrinology and metabolism.
[76] S. Matecki,et al. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. , 2012, The American journal of pathology.
[77] F. Leturcq,et al. Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation. , 2012, Human molecular genetics.
[78] E. Clementi,et al. Nitric Oxide in Myogenesis and Therapeutic Muscle Repair , 2012, Molecular Neurobiology.
[79] L. Schaefer,et al. Biglycan: a multivalent proteoglycan providing structure and signals. , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[80] Jamie L. Marshall,et al. Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. , 2012, Human Molecular Genetics.
[81] E. Mercuri,et al. The ever‐expanding spectrum of congenital muscular dystrophies , 2012, Annals of neurology.
[82] Kevin M Flanigan,et al. The Muscular Dystrophies , 1999, Seminars in Neurology.
[83] Jamie L. Marshall,et al. Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration , 2012, The Journal of cell biology.
[84] Xianhua Wang,et al. Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy , 2012, Science Translational Medicine.
[85] D. Allen,et al. Pathways of Ca²⁺ entry and cytoskeletal damage following eccentric contractions in mouse skeletal muscle. , 2012, Journal of applied physiology.
[86] Elaine Minatel,et al. Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice. , 2012, Nutrition.
[87] J. Mendell,et al. Emerging drugs for Duchenne muscular dystrophy , 2012, Expert opinion on emerging drugs.
[88] J. Sanes,et al. Interaction of α-Catulin with Dystrobrevin Contributes to Integrity of Dystrophin Complex in Muscle* , 2012, The Journal of Biological Chemistry.
[89] P. Muñoz-Cánoves,et al. Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor. , 2012, Human molecular genetics.
[90] T. Molinski,et al. Increased Resting Intracellular Calcium Modulates NF-κB-dependent Inducible Nitric-oxide Synthase Gene Expression in Dystrophic mdx Skeletal Myotubes* , 2012, The Journal of Biological Chemistry.
[91] Kay E. Davies,et al. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy , 2012, Nature.
[92] B. Allard,et al. Sarcoplasmic reticulum Ca2+ permeation explored from the lumen side in mdx muscle fibers under voltage control , 2012, The Journal of general physiology.
[93] O. Dorchies,et al. Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea , 2012, Histochemistry and Cell Biology.
[94] A. Nalini,et al. Oxidative Damage in Muscular Dystrophy Correlates with the Severity of the Pathology: Role of Glutathione Metabolism , 2012, Neurochemical Research.
[95] E. Hoffman,et al. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies , 2012, Mammalian Genome.
[96] H. Brenner,et al. Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin , 2011, The Journal of cell biology.
[97] P. Sestili,et al. Reactive Oxygen Species in Skeletal Muscle Signaling , 2011, Journal of signal transduction.
[98] R. Goldschmeding,et al. CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy , 2011, The Journal of pathology.
[99] W. Pratt,et al. Modulation of Heme/Substrate Binding Cleft of Neuronal Nitric-oxide Synthase (nNOS) Regulates Binding of Hsp90 and Hsp70 Proteins and nNOS Ubiquitination* , 2011, The Journal of Biological Chemistry.
[100] Masaaki Komatsu,et al. Autophagy: Renovation of Cells and Tissues , 2011, Cell.
[101] Angela Feechan,et al. S-nitrosylation of NADPH oxidase regulates cell death in plant immunity , 2011, Nature.
[102] J. Ervasti,et al. Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice , 2011, Skeletal Muscle.
[103] J. Tidball,et al. Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane , 2011, PloS one.
[104] Joe N. Kornegay,et al. Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy , 2011, Front. Pharmacol..
[105] Christopher W Ward,et al. X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart , 2011, Science.
[106] C. Hague,et al. Syntrophin isoforms play specific functional roles in the α1D-adrenergic receptor/DAPC signalosome. , 2011, Biochemical and biophysical research communications.
[107] J. Stamler,et al. Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4 , 2011, Proceedings of the National Academy of Sciences.
[108] P. Robbins,et al. Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology , 2011, Neurobiology of Disease.
[109] D. Duan,et al. iNOS Ablation Does Not Improve Specific Force of the Extensor Digitorum Longus Muscle in Dystrophin-Deficient mdx4cv Mice , 2011, PloS one.
[110] S. Messina,et al. Activation of NF-kB pathway in Duchenne muscular dystrophy: relation to age , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[111] S. Head,et al. The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy , 2011, Experimental physiology.
[112] K. Davies,et al. Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse , 2011, PloS one.
[113] C. Mann,et al. Aberrant repair and fibrosis development in skeletal muscle , 2011, Skeletal Muscle.
[114] P. Rosenberg,et al. The role of store-operated calcium influx in skeletal muscle signaling. , 2011, Cell calcium.
[115] G. Lamb,et al. Acute effects of reactive oxygen and nitrogen species on the contractile function of skeletal muscle , 2011, The Journal of physiology.
[116] T. L. Dutka,et al. Modulation of contractile apparatus Ca2+ sensitivity and disruption of excitation–contraction coupling by S‐nitrosoglutathione in rat muscle fibres , 2011, The Journal of physiology.
[117] C. Kee,et al. Myocilin Interacts with Syntrophins and Is Member of Dystrophin-associated Protein Complex* , 2011, The Journal of Biological Chemistry.
[118] T. Crawford,et al. Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders , 2011, Neurology.
[119] R. Hajjar,et al. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. , 2011, The Journal of clinical investigation.
[120] J. Faulkner,et al. Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats , 2011, The Journal of physiology.
[121] Karla P. García-Pelagio,et al. Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from normal and dystrophin-null mice , 2011, Journal of Muscle Research and Cell Motility.
[122] P. Yurchenco. Basement membranes: cell scaffoldings and signaling platforms. , 2011, Cold Spring Harbor perspectives in biology.
[123] J. Selsby. Increased catalase expression improves muscle function in mdx mice , 2011, Experimental physiology.
[124] Michael A. Freitas,et al. Peptide-Based Inhibition of NF-κB Rescues Diaphragm Muscle Contractile Dysfunction in a Murine Model of Duchenne Muscular Dystrophy , 2011, Molecular medicine.
[125] D. Duan,et al. Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin‐null mice , 2011, Journal of Pathology.
[126] J. Fallon,et al. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice , 2010, Proceedings of the National Academy of Sciences.
[127] S. Delp,et al. Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.
[128] D. Allen,et al. Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse , 2010, PloS one.
[129] Jeong-A Lim,et al. α-Syntrophin Modulates Myogenin Expression in Differentiating Myoblasts , 2010, PloS one.
[130] Jay J. Han,et al. The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observations , 2010, Muscle & nerve.
[131] P. Currie,et al. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology , 2010, Neuromuscular Disorders.
[132] L. Langeberg,et al. α-Dystrobrevin-1 recruits α-catulin to the α1D-adrenergic receptor/dystrophin-associated protein complex signalosome , 2010, Proceedings of the National Academy of Sciences.
[133] H. Sweeney,et al. Leupeptin-based inhibitors do not improve the mdx phenotype. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[134] P. Muñoz-Cánoves,et al. Regulation and dysregulation of fibrosis in skeletal muscle. , 2010, Experimental cell research.
[135] J. Beavo,et al. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.
[136] J. Mendell,et al. Dystrophin immunity in Duchenne's muscular dystrophy. , 2010, The New England journal of medicine.
[137] C. Ward,et al. Mitochondrial redox potential during contraction in single intact muscle fibers , 2010, Muscle & nerve.
[138] Jian Yang,et al. The ß subunit of voltage-gated Ca2+ channels. , 2010, Physiological reviews.
[139] Yu. V. Bodrov,et al. β2-Syntrophin Is a Cdk5 Substrate That Restrains the Motility of Insulin Secretory Granules , 2010, PloS one.
[140] S. Winder,et al. Dystrophin: more than just the sum of its parts. , 2010, Biochimica et biophysica acta.
[141] Lan-Fang Zhou,et al. Targeting Fibrosis in Duchenne Muscular Dystrophy , 2010, Journal of neuropathology and experimental neurology.
[142] A. Varki,et al. A Human-Specific Deletion in Mouse Cmah Increases Disease Severity in the mdx Model of Duchenne Muscular Dystrophy , 2010, Science Translational Medicine.
[143] R. Bloch,et al. Erratum to: Differential distribution of dystrophin and β-spectrin at the sarcolemma of fast twitch skeletal muscle fibers , 2010, Journal of Muscle Research and Cell Motility.
[144] F. von Wegner,et al. Upregulation of store-operated Ca2+ entry in dystrophic mdx mouse muscle. , 2010, American journal of physiology. Cell physiology.
[145] R. Penner,et al. Activation of store-operated I(CRAC) by hydrogen peroxide. , 2010, Cell calcium.
[146] B. Launikonis,et al. Toward the roles of store-operated Ca2+ entry in skeletal muscle , 2010, Pflügers Archiv - European Journal of Physiology.
[147] K. Davies,et al. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin , 2010, Journal of Cell Science.
[148] J. Kirschner,et al. Elevated satellite cell number in Duchenne muscular dystrophy , 2010, Cell and Tissue Research.
[149] S. Head. Branched fibres in old dystrophic mdx muscle are associated with mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a breakdown of Ca2+ homeostasis during fatigue , 2010, Experimental physiology.
[150] J. Chamberlain,et al. The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins , 2010, PLoS genetics.
[151] Paul L Huang,et al. Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. , 2010, The Journal of clinical investigation.
[152] A. Lambacher,et al. Integrin-Linked Kinase Controls Microtubule Dynamics Required for Plasma Membrane Targeting of Caveolae , 2010, Developmental cell.
[153] S. Schiaffino,et al. Regeneration of mammalian skeletal muscle. Basic mechanisms and clinical implications. , 2010, Current pharmaceutical design.
[154] C. Garbe,et al. Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. , 2010, Biophysical journal.
[155] C. Ingalls,et al. Junctophilin damage contributes to early strength deficits and EC coupling failure after eccentric contractions. , 2010, American journal of physiology. Cell physiology.
[156] F. Sotgia,et al. Caveolinopathies: from the biology of caveolin-3 to human diseases , 2010, European Journal of Human Genetics.
[157] G. Hause,et al. The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation , 2010, Histochemistry and Cell Biology.
[158] C. Cognard,et al. Regulation by scaffolding proteins of canonical transient receptor potential channels in striated muscle , 2009, Journal of Muscle Research and Cell Motility.
[159] S. Gibson,et al. TAPP2 links phosphoinositide 3-kinase signaling to B-cell adhesion through interaction with the cytoskeletal protein utrophin: expression of a novel cell adhesion-promoting complex in B-cell leukemia. , 2009, Blood.
[160] B. Aronow,et al. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.
[161] M. Jackson. Redox regulation of adaptive responses in skeletal muscle to contractile activity. , 2009, Free radical biology & medicine.
[162] C. Cognard,et al. Regulation of TRPC1 and TRPC4 Cation Channels Requires an α1-Syntrophin-dependent Complex in Skeletal Mouse Myotubes* , 2009, The Journal of Biological Chemistry.
[163] J. Tidball,et al. Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. , 2009, Human molecular genetics.
[164] D. Sandonà,et al. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects , 2009, Expert Reviews in Molecular Medicine.
[165] C. Ward,et al. Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. , 2009, American journal of physiology. Cell physiology.
[166] Jill L. Humston,et al. Dystrophin is a microtubule-associated protein , 2009, The Journal of cell biology.
[167] F. Leturcq,et al. Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated With Macrophage Alternative Activation , 2009, Journal of neuropathology and experimental neurology.
[168] A. Suzuki,et al. Intracellular polarity protein PAR‐1 regulates extracellular laminin assembly by regulating the dystroglycan complex , 2009, Genes to cells : devoted to molecular & cellular mechanisms.
[169] S. Hardy,et al. Mapping of the lipid-binding and stability properties of the central rod domain of human dystrophin. , 2009, Journal of molecular biology.
[170] E. Hoffman,et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. , 2009, The Journal of clinical investigation.
[171] J. Rabek,et al. Oxidative modification and aggregation of creatine kinase from aged mouse skeletal muscle , 2009, Aging.
[172] D. Burkin,et al. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy , 2009, Proceedings of the National Academy of Sciences.
[173] A. Brancaccio,et al. Functional diversity of dystroglycan. , 2009, Matrix biology : journal of the International Society for Matrix Biology.
[174] G. Lamb,et al. Involvement of calpains in Ca2+-induced disruption of excitation-contraction coupling in mammalian skeletal muscle fibers. , 2009, American journal of physiology. Cell physiology.
[175] H. Jarrett,et al. Dystrophin glycoprotein complex‐associated Gβγ subunits activate phosphatidylinositol‐3‐kinase/Akt signaling in skeletal muscle in a laminin‐dependent manner , 2009, Journal of cellular physiology.
[176] M. Nowycky,et al. Reciprocal amplification of ROS and Ca2+ signals in stressed mdx dystrophic skeletal muscle fibers , 2009, Pflügers Archiv - European Journal of Physiology.
[177] G. Lamb,et al. Plasma membrane removal in rat skeletal muscle fibers reveals caveolin-3 hot-spots at the necks of transverse tubules. , 2009, Experimental cell research.
[178] G. Lamb,et al. Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch* , 2009, Journal of Biological Chemistry.
[179] D. Duan,et al. Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. , 2009, The Journal of clinical investigation.
[180] Yuji Arai,et al. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. , 2009, Human molecular genetics.
[181] Gregory Q. Wallace,et al. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. , 2009, Annual review of physiology.
[182] S. Matecki,et al. Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle , 2009, Nature Medicine.
[183] M. Bahlo,et al. Mutations in contactin-1, a neural adhesion and neuromuscular junction protein, cause a familial form of lethal congenital myopathy. , 2008, American journal of human genetics.
[184] G. McConell,et al. Potential Role of Nitric Oxide in Contraction-stimulated Glucose Uptakeand Mitochondrial Biogenesis in Skeletal Muscle Does No/nos Regulate Contraction-stimulated Glucose Uptake? , 2022 .
[185] K. Bushby,et al. Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype? , 2008, Neuromuscular Disorders.
[186] S. Winder,et al. Dystroglycan, Tks5 and Src Mediated Assembly of Podosomes in Myoblasts , 2008, PloS one.
[187] Jamie L. Marshall,et al. Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complex , 2008, The Journal of cell biology.
[188] S. Baylor,et al. Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice , 2008, The Journal of physiology.
[189] O. Halevy,et al. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone , 2008, Neuromuscular Disorders.
[190] G. Kroemer,et al. Autophagic cell death: the story of a misnomer , 2008, Nature Reviews Molecular Cell Biology.
[191] A. Uezumi,et al. Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. , 2008, Experimental cell research.
[192] J. Chamberlain,et al. Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice , 2008, PloS one.
[193] R. Dirksen,et al. Differential dependence of store‐operated and excitation‐coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1 , 2008, The Journal of physiology.
[194] C. Moorwood,et al. Syncoilin, an intermediate filament-like protein linked to the dystrophin associated protein complex in skeletal muscle , 2008, Cellular and Molecular Life Sciences.
[195] D. Thedens,et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise , 2008, Nature.
[196] R. Grange,et al. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. , 2008, Journal of applied physiology.
[197] A. Moss,et al. α-1-Syntrophin Mutation and the Long-QT Syndrome: A Disease of Sodium Channel Disruption , 2008, Circulation. Arrhythmia and electrophysiology.
[198] D. Tester,et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS–SCN5A macromolecular complex , 2008, Proceedings of the National Academy of Sciences.
[199] C. Hague,et al. Blood Pressure Is Regulated by an α1D-Adrenergic Receptor/Dystrophin Signalosome* , 2008, Journal of Biological Chemistry.
[200] D. Allen,et al. TRPC1 binds to caveolin-3 and is regulated by Src kinase – role in Duchenne muscular dystrophy , 2008, Journal of Cell Science.
[201] J. Faulkner,et al. DIAPHRAGM MUSCLE STRIP PREPARATION FOR EVALUATION OF GENE THERAPIES IN mdx MICE , 2008, Clinical and experimental pharmacology & physiology.
[202] P. Carmeliet,et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. , 2008, Genes & development.
[203] J. Ervasti,et al. Skeletal Muscle-Specific Ablation of γcyto-Actin Does Not Exacerbate the mdx Phenotype , 2008, PloS one.
[204] G. Buonocore,et al. Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress , 2008, Brain and Development.
[205] C. Des Rosiers,et al. Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency , 2008, Proceedings of the National Academy of Sciences.
[206] Ning Wang,et al. Rapid signal transduction in living cells is a unique feature of mechanotransduction , 2008, Proceedings of the National Academy of Sciences.
[207] J. Chamberlain,et al. Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[208] D. Sherman,et al. The ABCA1 cholesterol transporter associates with one of two distinct dystrophin‐based scaffolds in Schwann cells , 2008, Glia.
[209] D. Allen,et al. N‐Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice , 2008, The Journal of physiology.
[210] O. Halevy,et al. Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone. , 2008, American journal of physiology. Heart and circulatory physiology.
[211] D. Felsenberg,et al. Ryanodine receptor type-1 (RyR1) expression and protein S-nitrosylation pattern in human soleus myofibres following bed rest and exercise countermeasure , 2008, Histochemistry and Cell Biology.
[212] S. Reiken,et al. Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity , 2008, Proceedings of the National Academy of Sciences.
[213] G. Truskey,et al. Mice Lacking Homer 1 Exhibit a Skeletal Myopathy Characterized by Abnormal Transient Receptor Potential Channel Activity , 2008, Molecular and Cellular Biology.
[214] V. A. Villar,et al. Lipid Rafts Keep NADPH Oxidase in the Inactive State in Human Renal Proximal Tubule Cells , 2008, Hypertension.
[215] D. Claflin,et al. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. , 2008, American journal of physiology. Cell physiology.
[216] A. Brunelle,et al. Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging Published, JLR Papers in Press, November 17, 2007. , 2008, Journal of Lipid Research.
[217] R. Brandes,et al. Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase. , 2008, Antioxidants & redox signaling.
[218] M. Kirkham,et al. PTRF-Cavin, a Conserved Cytoplasmic Protein Required for Caveola Formation and Function , 2008, Cell.
[219] M. Nowycky,et al. Reactive oxygen species contribute to Ca2+ signals produced by osmotic stress in mouse skeletal muscle fibres , 2008, The Journal of physiology.
[220] Kendra Anderson,et al. Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed α-dystrobrevin , 2008, Journal of Cell Science.
[221] M. Omary,et al. Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization , 2007, Journal of Cell Science.
[222] J. Chamberlain,et al. rAAV6‐Microdystrophin Rescues Aberrant Golgi Complex Organization in mdx Skeletal Muscles , 2007, Traffic.
[223] Y. Itoyama,et al. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.
[224] A. Meixner,et al. S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction , 2007, Nature Cell Biology.
[225] J. Morley,et al. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. , 2007, American journal of physiology. Cell physiology.
[226] B. Saltin. Exercise hyperaemia: magnitude and aspects on regulation in humans , 2007, The Journal of physiology.
[227] D. Allen,et al. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. , 2007, American journal of physiology. Heart and circulatory physiology.
[228] T. Südhof,et al. Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy , 2007, PloS one.
[229] K. Krause,et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. , 2007, The Biochemical journal.
[230] J. Gillis,et al. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin‐lacking mdx mice , 2007, The Journal of physiology.
[231] J. Lambeth. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. , 2007, Free radical biology & medicine.
[232] David P. Corey,et al. TRP channels in mechanosensation: direct or indirect activation? , 2007, Nature Reviews Neuroscience.
[233] S. Gee,et al. Morphological changes and spatial regulation of diacylglycerol kinase-zeta, syntrophins, and Rac1 during myoblast fusion. , 2007, Cell motility and the cytoskeleton.
[234] B. Nico,et al. Role of tumour necrosis factor α, but not of cyclo‐oxygenase‐2‐derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach , 2007, Neuropathology and applied neurobiology.
[235] Meenal Patel,et al. PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.
[236] F. Sachs,et al. Mechanosensitive channel properties and membrane mechanics in mouse dystrophic myotubes , 2007, The Journal of physiology.
[237] K. Davies,et al. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycan , 2007, The Journal of cell biology.
[238] J. Percival,et al. Golgi Complex Organization in Skeletal Muscle: A Role for Golgi‐Mediated Glycosylation in Muscular Dystrophies? , 2007, Traffic.
[239] Angela K. Peter,et al. Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. , 2007, Experimental cell research.
[240] E. McNally,et al. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. , 2007, Trends in cardiovascular medicine.
[241] F. Rivier,et al. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. , 2007, The American journal of pathology.
[242] Baohua Yang,et al. TNF-α potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells , 2007 .
[243] C. Cognard,et al. Regulation of capacitative calcium entries by α1‐syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of α1‐syntrophin , 2007 .
[244] Nicholas L. Cianciola,et al. The intermediate filament protein, synemin, is an AKAP in the heart. , 2006, Archives of biochemistry and biophysics.
[245] D. Allen,et al. Streptomycin reduces stretch-induced membrane permeability in muscles from mdx mice , 2006, Neuromuscular Disorders.
[246] B. Wong,et al. Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers , 2006, Neuromuscular Disorders.
[247] M. Rafii,et al. Biglycan binds to α‐ and γ‐sarcoglycan and regulates their expression during development , 2006 .
[248] M. Grounds,et al. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice , 2006, Neuromuscular Disorders.
[249] G. Lamb,et al. Ca2+ activation of diffusible and bound pools of μ‐calpain in rat skeletal muscle , 2006, The Journal of physiology.
[250] J. Percival,et al. γ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins , 2006 .
[251] O. Hamill,et al. Twenty odd years of stretch-sensitive channels , 2006, Pflügers Archiv.
[252] Dean P. Jones. Redefining oxidative stress. , 2006, Antioxidants & redox signaling.
[253] O. Dorchies,et al. Ca2+-independent phospholipase A2 enhances store-operated Ca2+ entry in dystrophic skeletal muscle fibers , 2006, Journal of Cell Science.
[254] P. Insel,et al. Microtubules and Actin Microfilaments Regulate Lipid Raft/Caveolae Localization of Adenylyl Cyclase Signaling Components* , 2006, Journal of Biological Chemistry.
[255] C. Hidalgo,et al. A Transverse Tubule NADPH Oxidase Activity Stimulates Calcium Release from Isolated Triads via Ryanodine Receptor Type 1 S -Glutathionylation* , 2006, Journal of Biological Chemistry.
[256] J. Ervasti,et al. Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. , 2006, Developmental cell.
[257] J. Lebacq,et al. Functional role of store‐operated and stretch‐activated channels in murine adult skeletal muscle fibres , 2006, The Journal of physiology.
[258] M. Rafii,et al. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[259] J. Heighway,et al. Over-expression of Microspan, a novel component of the sarcoplasmic reticulum, causes severe muscle pathology with triad abnormalities , 2006, Journal of Muscle Research & Cell Motility.
[260] D. Allen,et al. MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES , 2006, Clinical and experimental pharmacology & physiology.
[261] C. Bönnemann,et al. Congenital muscular dystrophies and the extracellular matrix. , 2006, Seminars in pediatric neurology.
[262] M. Boppart,et al. α7β1-Integrin regulates mechanotransduction and prevents skeletal muscle injury , 2006 .
[263] J. Fritschy,et al. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue , 2006, Cellular and Molecular Life Sciences CMLS.
[264] Bogdan Tanasa,et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function , 2006, Nature.
[265] L. Lands,et al. Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses. , 2006, The American journal of pathology.
[266] A. Bitto,et al. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. , 2006, The American journal of pathology.
[267] S. Snyder,et al. Alternatively spliced neuronal nitric oxide synthase mediates penile erection. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[268] H. Jarrett,et al. Binding of laminin α1-chain LG4-5 domain to α-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling , 2006 .
[269] O. Dorchies,et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. , 2006, American journal of physiology. Cell physiology.
[270] L. Birnbaumer,et al. Role of Src in C3 transient receptor potential channel function and evidence for a heterogeneous makeup of receptor- and store-operated Ca2+ entry channels. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[271] Francesco Muntoni,et al. Syncoilin upregulation in muscle of patients with neuromuscular disease , 2005, Muscle & nerve.
[272] M. Freeman,et al. Purification of ATP-binding Cassette Transporter A1 and Associated Binding Proteins Reveals the Importance of β1-Syntrophin in Cholesterol Efflux* , 2005, Journal of Biological Chemistry.
[273] M. DiFranco,et al. Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx mouse muscle fibres , 2005, The Journal of physiology.
[274] T. Sasaoka,et al. Molecular and cell biology of the sarcoglycan complex , 2005, Muscle & nerve.
[275] D. Discher,et al. Molecular extensibility of mini-dystrophins and a dystrophin rod construct. , 2005, Journal of molecular biology.
[276] Y. W. Chen,et al. Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy , 2005, Neurology.
[277] Andrea O'Neill,et al. Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. , 2005, Molecular biology of the cell.
[278] C. Kung,et al. A possible unifying principle for mechanosensation , 2005, Nature.
[279] Thomas W Prior,et al. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.
[280] E. Kudryashova,et al. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2005, Human molecular genetics.
[281] Shuo Luo,et al. α-Syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA4 signaling in an ARMS-dependent manner , 2005, The Journal of cell biology.
[282] S. Carbonetto,et al. Evidence That Dystroglycan Is Associated with Dynamin and Regulates Endocytosis* , 2005, Journal of Biological Chemistry.
[283] F. Salvatore,et al. Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity. , 2005, Annals of human genetics.
[284] Jianjie Ma,et al. Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle , 2005, Nature Cell Biology.
[285] F. Salvatore,et al. Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity , 2005 .
[286] K. North,et al. The Syntrophin-Dystrobrevin Subcomplex in Human Neuromuscular Disorders , 2005, Journal of neuropathology and experimental neurology.
[287] W. Catterall,et al. Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[288] Yuka Itoh,et al. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine , 2005, The journal of gene medicine.
[289] A. Kurosky,et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells , 2005, Nature Cell Biology.
[290] L. Kunkel. Cloning of the DMD Gene , 2005 .
[291] D. Allen,et al. Effects of stretch‐activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse , 2005, The Journal of physiology.
[292] D. Paulin,et al. Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle. , 2004, Experimental cell research.
[293] M. Lisanti,et al. Role of caveolae and caveolins in health and disease. , 2004, Physiological reviews.
[294] F. Muntoni,et al. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions , 2004, Neuropathology and applied neurobiology.
[295] K. Ohlendieck,et al. Subproteomics analysis of Ca2+‐binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle , 2004 .
[296] J. Tidball,et al. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. , 2004, Molecular genetics and metabolism.
[297] P. Kofuji,et al. The Potassium Channel Kir4.1 Associates with the Dystrophin-Glycoprotein Complex via α-Syntrophin in Glia* , 2004, Journal of Biological Chemistry.
[298] J. Yates,et al. Protein Trafficking and Anchoring Complexes Revealed by Proteomic Analysis of Inward Rectifier Potassium Channel (Kir2.x)-associated Proteins* , 2004, Journal of Biological Chemistry.
[299] M. DiFranco,et al. The action potential‐evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres , 2004, The Journal of physiology.
[300] Andrew Leask,et al. TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[301] K. Shitara,et al. α1-Syntrophin Modulates Turnover of ABCA1* , 2004, Journal of Biological Chemistry.
[302] B. Lévy,et al. Absence of Dystrophin in Mice Reduces NO-Dependent Vascular Function and Vascular Density: Total Recovery After a Treatment with the Aminoglycoside Gentamicin , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[303] M. Grounds,et al. Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis , 2004 .
[304] Yuko Sato,et al. Identification of Caveolin-1-interacting Sites in Neuronal Nitric-oxide Synthase , 2004, Journal of Biological Chemistry.
[305] B. van Deurs,et al. The phagocyte NADPH oxidase depends on cholesterol‐enriched membrane microdomains for assembly , 2004, The EMBO journal.
[306] P. Mcneil,et al. Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.
[307] M. Topham,et al. Diacylglycerol kinase-zeta localization in skeletal muscle is regulated by phosphorylation and interaction with syntrophins. , 2003, Molecular biology of the cell.
[308] M. Shigekawa,et al. TRPV2 Is a Component of Osmotically Sensitive Cation Channels in Murine Aortic Myocytes , 2003, Circulation research.
[309] Joseph P. Yuan,et al. Homer Binds TRPC Family Channels and Is Required for Gating of TRPC1 by IP3 Receptors , 2003, Cell.
[310] J. Gutkind,et al. Rac1 Function Is Required for Src-induced Transformation , 2003, Journal of Biological Chemistry.
[311] S. Miyamoto,et al. Initiation and Transduction of Stretch-induced RhoA and Rac1 Activation through Caveolae , 2003, Journal of Biological Chemistry.
[312] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[313] M. Wilson,et al. Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo. , 2003, Biochemistry.
[314] Steven M. Holland,et al. Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase‐2 (MMP‐2) via NAD(P)H Oxidase‐Derived Reactive Oxygen Species , 2003, Circulation research.
[315] E. Schiffrin,et al. c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[316] Chien-Chang Chen,et al. Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.
[317] G. Lynch,et al. Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx mice. , 2003, American journal of physiology. Cell physiology.
[318] J. Ervasti. Costameres: the Achilles' Heel of Herculean Muscle* 210 , 2003, The Journal of Biological Chemistry.
[319] I. Yuhanna,et al. Vasomodulation by Skeletal Muscle–Derived Nitric Oxide Requires &agr;-Syntrophin–Mediated Sarcolemmal Localization of Neuronal Nitric Oxide Synthase , 2003, Circulation research.
[320] T. Hashikawa,et al. Sast124, a novel splice variant of syntrophin-associated serine/threonine kinase (SAST), is specifically localized in the restricted brain regions , 2003, Neuroscience.
[321] J. Sanes,et al. Tyrosine-phosphorylated and nonphosphorylated isoforms of α-dystrobrevin , 2003, The Journal of Cell Biology.
[322] B. Sumpio,et al. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase. , 2003, Journal of vascular surgery.
[323] Ashok Kumar,et al. Mechanical stress activates the nuclear factor‐kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[324] D. Stephenson,et al. Identification of the coupling between skeletal muscle store-operated Ca2+ entry and the inositol trisphosphate receptor , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[325] Ole Petter Ottersen,et al. An α-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[326] Susan C. Brown,et al. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle , 2003, Neuromuscular Disorders.
[327] K. Davies,et al. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. , 2002, Human molecular genetics.
[328] Colin Chandler,et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation , 2002, Neuromuscular Disorders.
[329] M. Brand,et al. Topology of Superoxide Production from Different Sites in the Mitochondrial Electron Transport Chain* , 2002, The Journal of Biological Chemistry.
[330] Richard G. W. Anderson,et al. Dual control of caveolar membrane traffic by microtubules and the actin cytoskeleton , 2002, Journal of Cell Science.
[331] T. Rando. Oxidative Stress and the Pathogenesis of Muscular Dystrophies , 2002, American journal of physical medicine & rehabilitation.
[332] K. Campbell,et al. Loss of sarcolemma nNOS in sarcoglycan‐deficient muscle , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[333] R. Mellgren,et al. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. , 2002, Human molecular genetics.
[334] H. Debaix,et al. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers , 2002, The Journal of cell biology.
[335] Ying Tang,et al. Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice. , 2002, Human gene therapy.
[336] Eric P Hoffman,et al. Functional characteristics of dystrophic skeletal muscle: insights from animal models. , 2002, Journal of applied physiology.
[337] C. Huchet-Cadiou,et al. Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice , 2002, Pflügers Archiv.
[338] Y. Capetanaki,et al. Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres. , 2002, Molecular biology of the cell.
[339] Paul L Huang,et al. Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. , 2002, Endocrinology.
[340] G. Schmitz,et al. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. , 2002, Biochemical and biophysical research communications.
[341] Andrew P. Weir,et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. , 2002, Physiological reviews.
[342] A. Franco-Obregón,et al. Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse , 2002, The Journal of physiology.
[343] Dongsheng Duan,et al. Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy , 2002, Nature Medicine.
[344] Marius Sudol,et al. The WW domain: linking cell signalling to the membrane cytoskeleton. , 2002, Cellular signalling.
[345] N. Raben,et al. Phosphofructokinase deficiency; past, present and future. , 2002, Current molecular medicine.
[346] M. Bucan,et al. Running endurance abnormality in mdx mice , 2002, Muscle & nerve.
[347] S. Newey,et al. Association of Syncoilin and Desmin , 2002, The Journal of Biological Chemistry.
[348] S. Hussain,et al. Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. , 2002, American journal of respiratory and critical care medicine.
[349] M. Grounds,et al. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability , 2002, Journal of anatomy.
[350] B. Firestein,et al. Binding of Neuronal Nitric-oxide Synthase (nNOS) to Carboxyl-terminal-binding Protein (CtBP) Changes the Localization of CtBP from the Nucleus to the Cytosol , 2001, The Journal of Biological Chemistry.
[351] F. Sotgia,et al. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. , 2001, Biochemistry.
[352] P. Agre,et al. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[353] T. Rando. Role of nitric oxide in the pathogenesis of muscular dystrophies: A “two hit” hypothesis of the cause of muscle necrosis , 2001, Microscopy research and technique.
[354] J. Tidball,et al. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice , 2001, The Journal of cell biology.
[355] S. Froehner,et al. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4 , 2001, The Journal of cell biology.
[356] H. Jarrett,et al. Mouse alpha1-syntrophin binding to Grb2: further evidence of a role for syntrophin in cell signaling. , 2001, Biochemistry.
[357] S J Winder,et al. The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. , 2001, Cellular signalling.
[358] J. Faulkner,et al. Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old , 2001, The Journal of physiology.
[359] M. Solimena,et al. Dephosphorylation of β2‐syntrophin and Ca2+/μ‐calpain‐mediated cleavage of ICA512 upon stimulation of insulin secretion , 2001, The EMBO journal.
[360] E. Caler,et al. Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.
[361] G. Shao,et al. Prediction of amorphous phase stability in the metal–silicon systems , 2001 .
[362] J. Engelman,et al. Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule Abnormalities* , 2001, The Journal of Biological Chemistry.
[363] Simon C Watkins,et al. Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[364] Y. Ogawa,et al. Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres , 2001, The Journal of physiology.
[365] J. Fridén,et al. Serum creatine kinase level is a poor predictor of muscle function after injury , 2001, Scandinavian journal of medicine & science in sports.
[366] D. Bredt,et al. The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression , 2001, Muscle & nerve.
[367] C. Ponting,et al. Syncoilin, a Novel Member of the Intermediate Filament Superfamily That Interacts with α-Dystrobrevin in Skeletal Muscle* , 2001, The Journal of Biological Chemistry.
[368] J. Fridén,et al. Eccentric exercise-induced injuries to contractile and cytoskeletal muscle fibre components. , 2001, Acta physiologica Scandinavica.
[369] M. Reid,et al. highlighted topics Plasticity in Skeletal, Cardiac, and Smooth Muscle Invited Review: Redox modulation of skeletal muscle contraction: what we know and what we don’t , 2001 .
[370] C. Cognard,et al. Cationic channels in normal and dystrophic human myotubes , 2001, Neuromuscular Disorders.
[371] G. D. Thomas,et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[372] F. Sotgia,et al. Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members. , 2000, The Journal of biological chemistry.
[373] J. Chamberlain,et al. Muscular dystrophy: The worm turns to genetic disease , 2000, Current Biology.
[374] C. Ponting,et al. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex , 2000, Current Biology.
[375] A. Mondul,et al. Dystrophin Associates With Caveolae of Rat Cardiac Myocytes: Relationship to Dystroglycan , 2000, Circulation research.
[376] M. Solimena,et al. The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of β2-syntrophin and nNOS in pancreatic β-cells , 2000 .
[377] S. Fine,et al. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[378] P. Tonali,et al. γ1- and γ2-Syntrophins, Two Novel Dystrophin-binding Proteins Localized in Neuronal Cells* , 2000, The Journal of Biological Chemistry.
[379] H. Hama,et al. Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. , 2000, Human molecular genetics.
[380] R. Steinhardt,et al. Calcium Influx through Calcium Leak Channels Is Responsible for the Elevated Levels of Calcium-dependent Proteolysis in Dystrophic Myotubes* , 2000, The Journal of Biological Chemistry.
[381] J. Fallon,et al. The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle , 2000, The Journal of cell biology.
[382] G. Butler-Browne,et al. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children , 2000, Neuromuscular Disorders.
[383] Simon C Watkins,et al. Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein , 2000 .
[384] M. Badalamente,et al. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition , 2000, Muscle & nerve.
[385] H. Jarrett,et al. Phosphorylation of dystrophin and alpha-syntrophin by Ca(2+)-calmodulin dependent protein kinase II. , 1999, Biochimica et biophysica acta.
[386] J. Gillis,et al. Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse , 1999, Journal of Muscle Research & Cell Motility.
[387] F. Sotgia,et al. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. , 1999, Biochemical and biophysical research communications.
[388] Harry Hines Boulevard,et al. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies , 1999, Nature Cell Biology.
[389] G. Crawford,et al. Interactions between β2-syntrophin and a family of microtubule-associated serine/threonine kinases , 1999, Nature Neuroscience.
[390] E Bakker,et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study , 1999, The Lancet.
[391] J. Chamberlain,et al. Expression of the 71 kDa dystrophin isoform (Dp71) evaluated by gene targeting , 1999, Brain Research.
[392] W. Lim,et al. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. , 1999, Science.
[393] P. Cohen,et al. Stress-activated protein kinase-3 interacts with the PDZ domain of alpha1-syntrophin. A mechanism for specific substrate recognition. , 1999, The Journal of biological chemistry.
[394] D. Bredt,et al. Interaction of Neuronal Nitric-oxide Synthase and Phosphofructokinase-M* , 1999, The Journal of Biological Chemistry.
[395] J. Sanes,et al. Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.
[396] J. Sanes,et al. Role for α-Dystrobrevin in the Pathogenesis of Dystrophin-Dependent Muscular Dystrophies , 1999, Nature cell biology.
[397] K. Föhr,et al. Increased calcium entry into dystrophin‐deficient muscle fibres of MDX and ADR‐MDX mice is reduced by ion channel blockers , 1999, The Journal of physiology.
[398] J. Lefaucheur,et al. Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. , 1999, Journal of applied physiology.
[399] E. Ralston,et al. Caveolin-3 is associated with the T-tubules of mature skeletal muscle fibers. , 1999, Experimental cell research.
[400] P. Huang,et al. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[401] Nicolas Deconinck,et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice , 1998, Nature Medicine.
[402] M. Beal,et al. Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state , 1998, Journal of the Neurological Sciences.
[403] S. Ohki,et al. Solution structure of a protein inhibitor of neuronal nitric oxide synthase , 1998, Nature Structural Biology.
[404] J. Ervasti,et al. A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction* , 1998, The Journal of Biological Chemistry.
[405] B. Polla,,et al. Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. , 1998, Biochemical pharmacology.
[406] J. Sanes,et al. Differential Membrane Localization and Intermolecular Associations of α-Dystrobrevin Isoforms in Skeletal Muscle , 1998, The Journal of cell biology.
[407] R. Huganir,et al. Characterization of the tyrosine phosphorylation and distribution of dystrobrevin isoforms , 1998, FEBS letters.
[408] Wenrong Wu,et al. Increased caveolin‐3 levels in mdx mouse muscles , 1998, FEBS letters.
[409] K. Campbell,et al. Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex , 1998, FEBS letters.
[410] T. Rando,et al. Muscle cells from mdx mice have an increased susceptibility to oxidative stress , 1998, Neuromuscular Disorders.
[411] G. D. Thomas,et al. Nitric oxide mediates contraction‐induced attenuation of sympathetic vasoconstriction in rat skeletal muscle , 1998, The Journal of physiology.
[412] N. Hirokawa,et al. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.
[413] J. Caldwell,et al. Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins , 1998, The Journal of Neuroscience.
[414] L. Kunkel,et al. beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. , 1997, The Journal of biological chemistry.
[415] J. Ervasti,et al. Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association* , 1997, The Journal of Biological Chemistry.
[416] H. Ju,et al. Interaction of Neuronal Nitric-oxide Synthase with Caveolin-3 in Skeletal Muscle , 1997, The Journal of Biological Chemistry.
[417] J. Sanes,et al. Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.
[418] Susan C. Brown,et al. Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.
[419] G. Butler-Browne,et al. Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. , 1997, Human gene therapy.
[420] M. F. Peters,et al. Differential Association of Syntrophin Pairs with the Dystrophin Complex , 1997, The Journal of cell biology.
[421] Newbell Bj,et al. Ca2+-calmodulin binding to mouse alpha1 syntrophin: syntrophin is also a Ca2+-binding protein. , 1997 .
[422] V. Mildažienė,et al. Dependence of H2O2 Formation by Rat Heart Mitochondria on Substrate Availability and Donor Age , 1997, Journal of bioenergetics and biomembranes.
[423] J. Haycock,et al. Oxidative damage to muscle protein in Duchenne muscular dystrophy , 1996, Neuroreport.
[424] E. Hoffman,et al. Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex , 1996, Neuromuscular Disorders.
[425] S. Snyder,et al. PIN: An Associated Protein Inhibitor of Neuronal Nitric Oxide Synthase , 1996, Science.
[426] R. Steinhardt,et al. A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. , 1996, The American journal of physiology.
[427] J. Malin,et al. Muscle phosphofructokinase deficiency in two generations , 1996, Journal of Neurological Sciences.
[428] J. Stull,et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[429] D. Bredt,et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy , 1996, The Journal of experimental medicine.
[430] M. Lisanti,et al. Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.
[431] M. E. Kargacin,et al. The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle. , 1996, Biochimica et biophysica acta.
[432] J. A. Nichol,et al. Ca2+ loading reduces the tensile strength of sarcolemmal vesicles shed from rabbit muscle. , 1996, The Journal of physiology.
[433] D. Bredt,et al. Neuronal Nitric-oxide Synthase-, an Alternatively Spliced Isoform Expressed in Differentiated Skeletal Muscle (*) , 1996, The Journal of Biological Chemistry.
[434] M. F. Peters,et al. Isoform Diversity of Dystrobrevin, the Murine 87-kDa Postsynaptic Protein (*) , 1996, The Journal of Biological Chemistry.
[435] E. Chin,et al. The role of elevations in intracellular [Ca2+] in the development of low frequency fatigue in mouse single muscle fibres. , 1996, The Journal of physiology.
[436] D. Bredt,et al. Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.
[437] L. Lim,et al. The Ras-related GTPase Rac1 Binds Tubulin (*) , 1996, The Journal of Biological Chemistry.
[438] L. Kunkel,et al. The Three Human Syntrophin Genes Are Expressed in Diverse Tissues, Have Distinct Chromosomal Locations, and Each Bind to Dystrophin and Its Relatives (*) , 1996, The Journal of Biological Chemistry.
[439] P. Junankar,et al. Raised intracellular [Ca2+] abolishes excitation‐contraction coupling in skeletal muscle fibres of rat and toad. , 1995, The Journal of physiology.
[440] K. Widhalm,et al. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. , 1995, Neuropediatrics.
[441] R. Abresch,et al. Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.
[442] J. Mair,et al. Rapid Adaptation to Eccentric Exercise-Induced Muscle Damage , 1995, International journal of sports medicine.
[443] E. Hoffman,et al. Phospholipase A2 activity in dystrophinopathies , 1995, Neuromuscular Disorders.
[444] Isabelle Richard,et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.
[445] E. Elson,et al. Mechanical function of dystrophin in muscle cells , 1995, The Journal of cell biology.
[446] L. Kunkel,et al. Syntrophin binds to an alternatively spliced exon of dystrophin , 1995, The Journal of cell biology.
[447] E. Ozawa,et al. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice- prone region of the dystrophin COOH terminus , 1995, The Journal of cell biology.
[448] H. Jockusch,et al. Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. , 1995, Journal of cell science.
[449] R. Huganir,et al. Tyrosine and Serine Phosphorylation of Dystrophin and the 58‐kDa Protein in the Postsynaptic Membrane of Torpedo Electric Organ , 1994, Journal of neurochemistry.
[450] S. Snyder,et al. Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.
[451] M. S. Clarke,et al. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. , 1993, Journal of cell science.
[452] H. Sweeney,et al. Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. , 1993, The American journal of physiology.
[453] M. F. Peters,et al. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution , 1993, Neuron.
[454] J. Ervasti,et al. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.
[455] G. Maréchal,et al. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch , 1993, Journal of Muscle Research & Cell Motility.
[456] D. Allen,et al. Intracellular calcium concentration during low-frequency fatigue in isolated single fibers of mouse skeletal muscle. , 1993, Journal of applied physiology.
[457] J. Gillis,et al. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. , 1993, Cell calcium.
[458] V. Chapman,et al. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin , 1993, Nature Genetics.
[459] D. Bentley,et al. Exon structure of the human dystrophin gene. , 1993, Genomics.
[460] H. Sweeney,et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[461] R. Huganir,et al. The 87K postsynaptic membrane protein from torpedo is a protein-tyrosine kinase substrate homologous to dystrophin , 1993, Neuron.
[462] K. Bushby,et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy , 1993, Journal of Neurology.
[463] K. Bushby,et al. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy , 1993, Journal of Neurology.
[464] J. Ervasti,et al. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.
[465] J. Tidball,et al. Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. , 1992, Experimental cell research.
[466] Y. Nonomura,et al. Molecular shape of dystrophin. , 1992, Journal of biochemistry.
[467] O. Hutter,et al. The membrane hypothesis of duchenne muscular dystrophy: Quest for functional evidence , 1992, Journal of Inherited Metabolic Disease.
[468] M. Araki,et al. Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse , 1992, Journal of the Neurological Sciences.
[469] G. Porter,et al. Dystrophin Colocalizes with -spectrin in Distinct Subsarcolemmal Domains in Mammalian Skeletal Muscle , 1992 .
[470] O. Hutter,et al. Mechanical properties of normal andmdx mouse sarcolemma: Bearing on function of dystrophin , 1991, Journal of Muscle Research & Cell Motility.
[471] J. Shrager,et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.
[472] C. A. Peres,et al. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy , 1991, Journal of the Neurological Sciences.
[473] H. Jockusch,et al. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.
[474] H. Blau,et al. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy , 1990, Somatic cell and molecular genetics.
[475] J. Lansman,et al. Calcium entry through stretch-inactivated ion channels in mdx myotubes , 1990, Nature.
[476] L. Kunkel,et al. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.
[477] K. Davies,et al. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin , 1990, Nature.
[478] J. Miller,et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.
[479] B. Cooper,et al. Canine X-linked muscular dystrophy An animal model of Duchenne muscular dystrophy: Clinical studies , 1988, Journal of the Neurological Sciences.
[480] E. Nylander,et al. Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function , 1988, Acta neurologica Scandinavica.
[481] R. Steinhardt,et al. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice , 1988, Nature.
[482] A. Sevanian,et al. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation. , 1988, Biochimica et biophysica acta.
[483] Jamel Chelly,et al. Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.
[484] Simon C Watkins,et al. Immunoelectron microscopic localization of dystrophin in myofibres , 1988, Nature.
[485] H. Blau,et al. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy , 1988, Cell.
[486] M. Zatz,et al. Relation between height and clinical course in Duchenne muscular dystrophy. , 1988, American journal of medical genetics.
[487] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[488] A. Monaco,et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.
[489] Simon C Watkins,et al. A quantitative comparison of satellite cell ultrastructure in duchenne muscular dystrophy, polymyositis, and normal controls , 1986, Muscle & nerve.
[490] L. Kunkel,et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy , 1986, Nature.
[491] I. Gamstorp,et al. A Trial of Selenium and Vitamin E in Boys With Muscular Dystrophy , 1986, Journal of child neurology.
[492] J. Putney,et al. A model for receptor-regulated calcium entry. , 1986, Cell calcium.
[493] Simon C Watkins,et al. HISTOCHEMICAL FIBRE TYPING AND ULTRASTUCTURE OF THE SMALL FIBRES IN DUCHENNE MUSCULAR DYSTROPHY , 1985, Neuropathology and applied neurobiology.
[494] A. Monaco,et al. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[495] H. Kainulainen,et al. Vitamin E deficiency and the susceptibility to lipid peroxidation of mouse cardiac and skeletal muscles. , 1984, Acta physiologica Scandinavica.
[496] F Sachs,et al. Stretch‐activated single ion channel currents in tissue‐cultured embryonic chick skeletal muscle. , 1984, The Journal of physiology.
[497] H. Willard,et al. Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. , 1984, Science.
[498] K. Moore,et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[499] H. Blau,et al. Defective myoblasts identified in Duchenne muscular dystrophy. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[500] K. Davies,et al. Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. , 1983, Nucleic acids research.
[501] S. Street,et al. Lateral transmission of tension in frog myofibers: A myofibrillar network and transverse cytoskeletal connections are possible transmitters , 1983, Journal of cellular physiology.
[502] R. J. Pellegrino,et al. Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. , 1982, Archives of neurology.
[503] M. Hallett,et al. Muscle phosphofructokinase deficiency , 1981, Neurology.
[504] K. Fischbeck,et al. Freeze-fracture studies of muscle caveolae in human muscular dystrophy. , 1981, The American journal of pathology.
[505] L. Tomasi. Reversibility of human myopathy caused by vitamin E deficiency , 1979, Neurology.
[506] J. Bodensteiner,et al. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies , 1978, Neurology.
[507] P A Merton,et al. Fatigue of long duration in human skeletal muscle after exercise. , 1977, The Journal of physiology.
[508] B. Mokri,et al. Duchenne dystrophy , 1975, Neurology.
[509] W. Bradley,et al. Failure to confirm a vascular cause of muscular dystrophy. , 1975, Archives of neurology.
[510] Becker Pe. Two families of benign sex-linked recessive muscular dystrophy. , 1962 .
[511] Michael P. Siegel,et al. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. , 2013, Human molecular genetics.
[512] Jian Yang,et al. Structure and function of the β subunit of voltage-gated Ca 2+ channels , 2013 .
[513] G. Wiche,et al. The many faces of plectin and plectinopathies: pathology and mechanisms , 2012, Acta Neuropathologica.
[514] John K. Hall,et al. Animal models of muscular dystrophy. , 2012, Progress in molecular biology and translational science.
[515] C. Bourcier-Lucas,et al. Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. , 2011, American journal of physiology. Heart and circulatory physiology.
[516] C. Minetti,et al. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. , 2011, Handbook of clinical neurology.
[517] C. Mann,et al. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. , 2011, Current topics in developmental biology.
[518] J. Beavo,et al. Evaluation of the therapeutic utility of phosphodiesterase 5A inhibition in the mdx mouse model of duchenne muscular dystrophy. , 2011, Handbook of experimental pharmacology.
[519] Y. Hayashi,et al. The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b. , 2010, Biochemical and biophysical research communications.
[520] L. Birnbaumer,et al. Role of TRPC1 channel in skeletal muscle function. , 2010, American journal of physiology. Cell physiology.
[521] G. Isenberg,et al. Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels. , 2009, Cell Calcium.
[522] E. Ríos. The cell boundary theorem: a simple law of the control of cytosolic calcium concentration , 2009, The Journal of Physiological Sciences.
[523] J. Chamberlain,et al. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies. , 2008, Current topics in developmental biology.
[524] D. Allen,et al. Skeletal muscle fatigue: cellular mechanisms. , 2008, Physiological reviews.
[525] Baohua Yang,et al. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. , 2007, American journal of physiology. Heart and circulatory physiology.
[526] C. Cognard,et al. Regulation of capacitative calcium entries by alpha1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of alpha1-syntrophin. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[527] Nicola Maffulli,et al. Creatine kinase monitoring in sport medicine. , 2007, British medical bulletin.
[528] A. Kurosky,et al. Revisiting TRPC1 and TRPC6 mechanosensitivity , 2007, Pflügers Archiv - European Journal of Physiology.
[529] K. Krause,et al. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.
[530] D. Leibfritz,et al. Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.
[531] M. Rafii,et al. Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. , 2006, Journal of cellular physiology.
[532] D. Burkin,et al. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. , 2006, Journal of cell science.
[533] M. Boppart,et al. Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury. , 2006, American journal of physiology. Cell physiology.
[534] J. Percival,et al. gamma-Syntrophin scaffolding is spatially and functionally distinct from that of the alpha/beta syntrophins. , 2006, Experimental cell research.
[535] H. Jarrett,et al. Binding of laminin alpha1-chain LG4-5 domain to alpha-dystroglycan causes tyrosine phosphorylation of syntrophin to initiate Rac1 signaling. , 2006, Biochemistry.
[536] L. Kunkel. 2004 William Allan Award address. Cloning of the DMD gene. , 2005, American journal of human genetics.
[537] Gregory Q. Wallace,et al. Transgenic Expression of (cid:1) 7 (cid:2) 1 Integrin Maintains Muscle Integrity, Increases Regenerative Capacity, Promotes Hypertrophy, and Reduces Cardiomyopathy in Dystrophic Mice , 2004 .
[538] Y. Wakayama,et al. Size and localization of dystrophin molecule: immunoelectron microscopic and freeze etching studies of muscle plasma membranes of murine skeletal myofibers , 2004, Acta Neuropathologica.
[539] M. Rudnicki,et al. Cellular and molecular regulation of muscle regeneration. , 2004, Physiological reviews.
[540] K. Shitara,et al. Alpha1-syntrophin modulates turnover of ABCA1. , 2004, The Journal of biological chemistry.
[541] R. Bloch,et al. Differential distribution of dystrophin and β-spectrin at the sarcolemma of fast twitch skeletal muscle fibers , 2004, Journal of Muscle Research & Cell Motility.
[542] M. Grounds,et al. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[543] K. Mathews,et al. Limb-girdle muscular dystrophy , 2003, Current neurology and neuroscience reports.
[544] J. Sanes,et al. Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions. , 2003, The Journal of cell biology.
[545] J. Stamler,et al. Physiology of nitric oxide in skeletal muscle. , 2001, Physiological reviews.
[546] Simon C Watkins,et al. Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[547] K. Suzuki,et al. Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. , 2000, Advances in Experimental Medicine and Biology.
[548] M. Solimena,et al. The receptor tyrosine phosphatase-like protein ICA512 binds the PDZ domains of beta2-syntrophin and nNOS in pancreatic beta-cells. , 2000, European journal of cell biology.
[549] P. Tonali,et al. Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. , 2000, The Journal of biological chemistry.
[550] D. Bredt,et al. Regulation of neuronal nitric oxide synthase through alternative transcripts. , 1997, Developmental neuroscience.
[551] H. Jarrett,et al. Ca2+-calmodulin binding to mouse alpha1 syntrophin: syntrophin is also a Ca2+-binding protein. , 1997, Biochemistry.
[552] D. A. Williams,et al. Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. , 1993, The Journal of physiology.
[553] P. Mcneil,et al. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. , 1992, The American journal of pathology.
[554] D. A. Williams,et al. Physiological properties of skinned fibres from normal and dystrophic (Duchenne) human muscle activated by Ca2+ and Sr2+. , 1990, The Journal of physiology.
[555] A. Sevanian,et al. Phospholipase A2 dependent release of fatty acids from peroxidized membranes. , 1985, Journal of free radicals in biology & medicine.
[556] M. Zatz,et al. Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency. , 1981, American journal of medical genetics.
[557] M. Zatz,et al. Begnign duchenne muscular dystrophy in a patient with growth hormone deficiency , 1981 .
[558] A. Ossipov,et al. Duchenne muscular dystrophy , 2004 .
[559] P. E. Becker. Two families of benign sex-linked recessive muscular dystrophy. , 1962, Revue canadienne de biologie.